* Liquidia Corp LQDA.OQ reported a quarterly adjusted loss
of 42
cents per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -9
cents. The mean expectation of seven analysts for the quarter
was for a loss of 24 cents per share. Wall Street expected
results to range from -25 cents to -22 cents per share.
* Revenue fell 15.5% to $4.53 million from a year ago;
analysts
expected $4.73 million.
* Liquidia Corp's reported EPS for the quarter was a loss
of 42
cents.
* The company reported a quarterly loss of $27.45 million.
* Liquidia Corp shares had risen by 16.2% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Liquidia Corp is
$25.00
This summary was machine generated from LSEG data March 13 at
01:30 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.24 -0.42 Missed
Sep. 30 2023 -0.21 -0.24 Missed
Jun. 30 2023 -0.16 -0.36 Missed
Mar. 31 2023 -0.16 -0.18 Missed